-+ 0.00%
-+ 0.00%
-+ 0.00%

Laekna's Oral Obesity Drug LAE124 Reduces Body Weight in Rat Studies

PUBT·11/12/2026 04:04:06
Laekna's Oral Obesity Drug LAE124 Reduces Body Weight in Rat Studies
  • Laekna will present animal-study results for oral obesity drug LAE124 at Obesity Week on Nov. 15, 2026, in Washington, D.C.
  • LAE124 reduced food intake and body weight in obese rats, with stronger effects at higher doses.
  • Animal studies showed a favorable safety profile with low drug-interaction risk, supporting potential combinations with other weight-loss therapies.
  • The drug remains in IND-enabling studies; its predicted pharmacokinetic profile supports low-dose, once-daily oral use in humans.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Laekna Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202611112301PR_NEWS_USPR_____CN96086) on November 12, 2026, and is solely responsible for the information contained therein.